Zobrazeno 1 - 10
of 21
pro vyhledávání: '"J J, Dignam"'
Autor:
E. B. Lamont, D. Hayreh, K. E. Pickett, J. J. Dignam, M. A. List, K. M. Stenson, D. J. Haraf, B. E. Brockstein, S. A. Sellergren, E. E. Vokes
Publikováno v:
JNCI Journal of the National Cancer Institute. 95:1370-1375
Publikováno v:
Neurochirurgie Scan. :256-257
Publikováno v:
Controlled clinical trials. 19(6)
Although several randomized clinical trials in the 1980s indicated a benefit from the use of tamoxifen in the treatment of early-stage breast cancer, questions have remained regarding the optimal duration of drug administration. In 1982, the National
Publikováno v:
Cancer. 80(1)
A disparity in breast carcinoma survival between African-American and white women has been noted over the past several decades. A major factor implicated in this disparity is stage of disease at diagnosis. In this study, survival and related endpoint
Autor:
Blase N. Polite, Mark J. Ratain, J. J. Dignam, Lee N. Newcomer, G. C. Alexander, Neal J. Meropol, S. Zhu, J.A. de Souza
Publikováno v:
Journal of Clinical Oncology. 29:6002-6002
6002 Background: New biologic and cytotoxic therapies have successfully improved mCC survival, yet have the potential to increase the use of non-EBM regimens. Insight into utilization patterns of n...
Autor:
B. Fisher, J. J. Dignam
Publikováno v:
JNCI Journal of the National Cancer Institute. 93:1421-1422
Autor:
Xie W; Dana-Farber Cancer Institute, Boston, USA., Ravi P; Dana-Farber Cancer Institute, Boston, USA., Buyse M; International Drug Development Institute, Louvain-la-Neuve; I-BioStat, Hasselt University, Hasselt, Belgium., Halabi S; Duke University, Durham., Kantoff P; Convergent Therapeutics, Cambridge., Sartor O; Mayo Clinic, Rochester., Soule H; Prostate Cancer Foundation, Santa Monica, USA., Clarke N; The Christie NHS Foundation Trust, Manchester, UK., Dignam J; University of Chicago, Chicago, USA., James N; The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK., Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif, France., Gillessen S; Oncology Institute of Southern Switzerland, EOC, Bellinzona; Università della Svizzera Italiana, Lugano, Switzerland., Mottet N; Mutualite Francoise Loire, St Etienne, France., Murphy L; Medical Research Council at UCL, London, UK., Parulekar W; Queens University, Kingston, Ontario, Canada., Sandler H; Cedars-Sinai Medical Center, Los Angeles, USA., Tombal B; Cliniques Universitaires Saint-Luc, Brussels, Belgium., Williams S; Peter MacCallum Cancer Centre, Melbourne., Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia. Electronic address: Christopher.sweeney@adelaide.edu.au.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Mar; Vol. 35 (3), pp. 285-292. Date of Electronic Publication: 2023 Dec 05.
Autor:
Fisher B; National Surgical Adjuvant Breast and Bowel Project, and Department of Surgery, University of Pittsburgh, PA 15212-5234, USA. bernard.fisher@nsabp.org, Dignam J, Bryant J, Wolmark N
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2001 May 02; Vol. 93 (9), pp. 684-90.
Autor:
Fisher B; B. Fisher, National Surgical Adjuvant Breast and Bowel Project (NSABP), Pittsburgh, PA, USA. bernard.fisher@nsabp.org, Dignam J, Tan-Chiu E, Anderson S, Fisher ER, Wittliff JL, Wolmark N
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2001 Jan 17; Vol. 93 (2), pp. 112-20.